Human colorectal cancer progression correlates with LOX-induced ECM stiffening

Bo Wei,Xueling Zhou,Chenghua Liang,Xiaoming Zheng,Purun Lei,Jiafeng Fang,Xiaoyan Han,Lijing Wang,Cuiling Qi,Hongbo Wei
DOI: https://doi.org/10.7150/ijbs.21230
2017-01-01
International Journal of Biological Sciences
Abstract:Some solid tumors are characterized by extracellular matrix (ECM) remodeling and stiffening, which is related to solid tumor progression and aggression. However, the relationship between ECM stiffness and colorectal cancer (CRC) remains unclear. In this study, we investigated the relevance of ECM stiffness to clinicopathologic features using human CRC tissue microarrays. The results demonstrate that the expression of ECM components in CRC tissues is closely correlated with CRC progression and poor prognosis, which indicates that ECM stiffness may be associated with CRC development. We further studied lysyl oxidase (LOX) expression in CRC tissue and demonstrated that LOX expression is closely correlated with CRC progression. Previous studies showed that P-selectin-mediated platelet accumulation in CRC tissue may up-regulate LOX expression. Our findings indicate that P-selectin-mediated platelet aggregation may up-regulate LOX expression and enhance the remodeling and stiffening of the tumor ECM, which may promote the progression of colorectal cancer. Therefore, LOX may be a potential effective therapeutic target to treat colorectal cancer.
biochemistry & molecular biology
What problem does this paper attempt to address?